Mensing Can't Keep Bristol-Myers' Plavix Suits Federal

Law360, New York (August 10, 2012, 7:59 PM EDT) -- Bristol-Myers Squibb Co. and McKesson Corp. on Friday lost a bid to keep eight lawsuits alleging harm from cardiovascular drug Plavix in California federal court, in part because a judge declined to extend the U.S. Supreme Court’s ruling in Pliva v. Mensing as far as requested.

In an attempt to preserve federal jurisdiction, Bristol-Myers said California-based McKesson shouldn’t be named in the case because, as a distributor, it lacked power to change drug labels and therefore was shielded by Mensing. That ruling last year said generic...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Bales et al v. Bristol-Myers Squibb Company et al


Case Number

3:12-cv-01821

Court

California Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Edward M. Chen

Date Filed

April 11, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.